Mercaptopurine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Mercaptopurine and local guidelines before prescribing.
Antimetabolite
Mechanism
Purine analogue; active metabolite of azathioprine.
Uses
Acute lymphoblastic leukaemia, Crohn disease, ulcerative colitis.
Dosing
- Thiopurines - azathioprine (2–2.5 mg/kg/day) and mercaptopurine (1–1.5 mg/kg/day):
Gastroenterology: Inflammatory Bowel Disease - Mercaptopurine 1–1.5 mg/kg/day | As azathioprine; sometimes better tolerated.
Gastroenterology: Inflammatory Bowel Disease - Allopurinol — xanthine oxidase inhibitor — start low (100 mg daily, lower in CKD) and titrate monthly to a target urate under 360 µmol/L (under 300 if tophi or frequent flares); risks — rash, severe cutaneous reactions (SJS/TEN, DRESS — HLA-B*58:01 in Han Chinese, Thai and Korean ancestry); azathioprine and mercaptopurine interaction …
Rheumatology Anatomy Physiology Pharmacology
Side effects
Myelosuppression, hepatotoxicity, nausea, pancreatitis.
Interactions
Allopurinol greatly increases toxicity (reduce dose to a quarter); warfarin effect reduced.
Contraindications and cautions
Severe marrow suppression
Monitoring
FBC, LFT
Pregnancy and breastfeeding
Use if essential
Renal and hepatic impairment
Reduce dose in renal and hepatic impairment
Overdose and reversal
Supportive
Special advice
Check TPMT or NUDT15 before starting.
More from the textbook: uses, cautions and other points
- Azathioprine / mercaptopurine | Check TPMT; marrow suppression, pancreatitis, skin cancer; avoid allopurinol.
Gastroenterology: Anatomy Physiology Pharmacology - Azathioprine | Purine analogue (6-mercaptopurine) — inhibits lymphocyte proliferation | Check TPMT ; marrow suppression; allopurinol interaction ; skin cancer
Rheumatology Anatomy Physiology Pharmacology - Interaction - azathioprine and mercaptopurine with allopurinol or febuxostat → severe marrow toxicity - avoid or greatly reduce the dose (specialist).
Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain - Important examples : Gene Drug Effect TPMT (and NUDT15) Azathioprine, mercaptopurine Low activity → severe bone marrow suppression - test before starting DPYD 5-fluorouracil, capecitabine Deficiency → severe, potentially fatal toxicity - test before starting (UK standard) HLA-B*57:01 Abacavir (HIV) Hypersensitivity reaction - test before …
Clinical pharmacology and prescribing: Principles of clinical pharmacology - TPMT and NUDT15 | Azathioprine, mercaptopurine | Severe myelosuppression in deficiency - check TPMT before starting ; reduce dose or avoid
Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics - Drugs targeting nucleotide synthesis: methotrexate (dihydrofolate reductase), 5-fluorouracil (thymidylate synthase), hydroxycarbamide (ribonucleotide reductase), mycophenolate (IMP dehydrogenase - lymphocytes depend on de novo purine synthesis), azathioprine/6-mercaptopurine (purine analogues; TPMT activity predicts toxicity), …
Biochemistry: Metabolism of carbohydrates, lipids and proteins - Azathioprine or mercaptopurine ; methotrexate if thiopurines are not tolerated.
Gastroenterology: Inflammatory Bowel Disease - ⚠️ Safety Pearl: Two drug-mechanism traps cause deaths every year. Methotrexate is once WEEKLY — daily dosing causes fatal marrow failure. And allopurinol blocks the enzyme that clears azathioprine and mercaptopurine — combining them without a large dose reduction causes severe myelosuppression.
Rheumatology Anatomy Physiology Pharmacology
Where it is discussed in the book
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Inflammatory Bowel Disease (3 mentions)
- Rheumatology Anatomy Physiology Pharmacology (3 mentions)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (3 mentions)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (1 mention)
- Biochemistry: Metabolism of carbohydrates, lipids and proteins (2 mentions)